John MichaelTateMD

Oncology • Willmar, MN

Physician

Join to view full profile

Dr. Tate is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Tate's full profile

Already have an account?

Office
n/a
Willmar, MN 56201
Is this information wrong?

Education & Training

Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1994 - 1997
Cleveland Clinic FoundationResidency, Internal Medicine, 1992 - 1994
Cleveland Clinic FoundationInternship, Internal Medicine, 1991 - 1992
University of North Dakota School of Medicine and Health SciencesClass of 1991

Certifications & Licensure

OH State Medical License 1993 - 2025
ND State Medical License 2000 - 2025
MN State Medical License 2001 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Publications & Presentations

PubMed

15 citations
Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients
Robert K. Sylvester, Preston D. Steen, John M. Tate, Minesh Mehta, Ryan J. Petrich, Alexander Berg, Jill M. Kolesar> ;Anti-Cancer Drugs. 2011 Jan 1
78 citations
A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503
Anne M. Traynor, Ju Whei Lee, Gerald Bayer, John M. Tate, Sachdev P. Thomas, Miroslaw Mazurczak, David L. Graham, Jill M. Kolesar, Joan H. Schiller> ;Investigational New Drugs. 2010 Feb 1
ECOG 1503: A phase II trial of triapine (NSC#663249) with gemcitabine (T/G) as 2nd line treatment of non-small cell lung cancer (NSCLC).
Traynor AM, Levy DE, Bayer GK, Tate JM, Thomas SP, Mazurczak MA, Graham DL, Kolesar JM, Schiller JH> ;J. Clin. Oncol.. 2006-06-20
20 citations
Plasma Cell Pleocytosis in Cerebrospinal Fluid in Patients with West Nile Virus Encephalitis
Paul J. Carson, Thomas Steidler, Roberto L. Patron, John M. Tate, Robert Tight, Raymond A. Smego> ;Clinical Infectious Diseases. 2003 Jul 1
16 citations
Primary cell culture and morphological characterization of ventricular myocytes from the adult newt, Notophthalmus viridescens.
John M. Tate, John O. Oberpriller> ;The Anatomical Record. 1989 May 1
10 citations
Analysis of DNA synthesis in cell cultures of the adult newt cardiac myocyte
John M. Tate, John O. Oberpriller, Jean C. Oberpriller> ;Tissue & Cell. 1989 Jan 1
7 citations
Isolation of cardiac myocytes from the adult newt, Notophthalmus viridescens. an electron microscopic and quantitative light microscopic analysis.
John M. Tate, Timothy J. McDonnell, Jean C. Oberpriller, John O. Oberpriller> ;Tissue & Cell. 1987 Jan 1
Join now to see all

Hospital Affiliations

Lake Region Healthcare CorporationFergus Falls, Minnesota
Essentia Health FargoFargo, North Dakota
Rice Memorial HospitalWillmar, Minnesota